Aptose Biosciences Inc. – TSX:APS.TO

Aptose Biosciences stock price today

CAD 1.73
+1.39
+408.82%
Financial Health
0
1
2
3
4
5
6
7
8
9

Aptose Biosciences stock price monthly change

-63.83%
month

Aptose Biosciences stock price quarterly change

-63.83%
quarter

Aptose Biosciences stock price yearly change

-89.88%
year

Aptose Biosciences key metrics

Market Cap
 20.53M
Enterprise value
 38.72M
P/E
 -1.26
EV/Sales
 N/A
EV/EBITDA
 -0.70
Price/Sales
 N/A
Price/Book
 1.41
PEG ratio
 0.14
EPS
 -1561.56
Revenue
 N/A
EBITDA
 -47.57M
Income
 -47.17M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Aptose Biosciences stock price history

Aptose Biosciences stock forecast

Aptose Biosciences financial statements

Profit Margin

Aptose Biosciences Inc. (TSX:APS.TO): Profit margin
Jun 2023 0 -14.12M
Sep 2023 0 -11.44M
Dec 2023 0 -11.95M
Mar 2024 0 -9.64M
APS.TO income statement history

Aptose Biosciences Financials Estimate

Aptose Biosciences Inc. (TSX:APS.TO): Analyst Estimates
Mar 2024 0 -9.64M
Sep 2025 0 -10.64M
Dec 2025 0 -5.47M
Dec 2025 0 -11.99M

  • Analysts Price target

  • Financials & Ratios estimates

Show more

Debt to Assets

Aptose Biosciences Inc. (TSX:APS.TO): Debt to assets
Jun 2023 26575000 12.78M 48.12%
Sep 2023 20876000 13.1M 62.75%
Dec 2023 12989000 15.89M 122.33%
Mar 2024 12796000 12.65M 98.93%
APS.TO balance sheet history

Cash Flow

Aptose Biosciences Inc. (TSX:APS.TO): Cash Flow
Jun 2023 -13.50M -1.96M 1.10M
Sep 2023 -10.53M 12.95M 4.90M
Dec 2023 -9.25M 1.93M 854K
Mar 2024 -11.76M -1.99M 11.84M
APS.TO cash flow history

Aptose Biosciences alternative data

Aptose Biosciences
Employees

Aptose Biosciences Inc. (TSX:APS.TO): Employee count
Aug 2023 35
Sep 2023 35
Oct 2023 35
Nov 2023 35
Dec 2023 35
Jan 2024 35
Feb 2024 35
Mar 2024 35
Apr 2024 35
May 2024 35
Jun 2024 35
Jul 2024 35

Aptose Biosciences other data

Frequently Asked Questions (FAQ)

  • What's the price of Aptose Biosciences stock today?

    One share of Aptose Biosciences stock can currently be purchased for approximately $1.73.

  • When is Aptose Biosciences's next earnings date?

    Unfortunately, Aptose Biosciences's (APS.TO) next earnings date is currently unknown.

  • Does Aptose Biosciences pay dividends?

    No, Aptose Biosciences does not pay dividends.

  • How much money does Aptose Biosciences make?

    Aptose Biosciences has a market capitalization of 20.53M.

  • What is Aptose Biosciences's stock symbol?

    Aptose Biosciences Inc. is traded on the TSX under the ticker symbol "APS.TO".

  • What is Aptose Biosciences's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Aptose Biosciences?

    Shares of Aptose Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Aptose Biosciences's key executives?

    Aptose Biosciences's management team includes the following people:

    • Dr. William G. Rice Ph.D. Chairman, Pres & Chief Executive Officer(age: 66, pay: $898,830)
    • Dr. Jotin Marango Ph.D., M.D. Senior Vice President, Chief Financial Officer, Chief Accounting Officer & Chief Bus. Officer(age: 46, pay: $573,660)
    • Dr. Rafael Bejar M.D., Ph.D. Senior Vice President & Chief Medical Officer(age: 53, pay: $566,920)

  • How many employees does Aptose Biosciences have?

    As Jul 2024, Aptose Biosciences employs 35 workers.

  • When Aptose Biosciences went public?

    Aptose Biosciences Inc. is publicly traded company for more then 29 years since IPO on 25 Apr 1996.

  • What is Aptose Biosciences's official website?

    The official website for Aptose Biosciences is aptose.com.

  • Where are Aptose Biosciences's headquarters?

    Aptose Biosciences is headquartered at 251 Consumers Road, Toronto, ON.

  • How can i contact Aptose Biosciences?

    Aptose Biosciences's mailing address is 251 Consumers Road, Toronto, ON and company can be reached via phone at +1 650 718 5028.

Aptose Biosciences company profile:

Aptose Biosciences Inc.

aptose.com
Exchange:

TSX

Full time employees:

35

Industry:

Biotechnology

Sector:

Healthcare

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, which is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and various non-Hodgkin's lymphomas, as well as AML and HR MDS; and APL-581, a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program. It has agreements with CrystalGenomics, Inc. and OHM Oncology. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.

+1 650 718 5028
251 Consumers Road
Toronto, ON M2J 4R3

:
ISIN: CA03835T3091
: